Close X
Friday, November 29, 2024
ADVT 
International

Stanford Rape Case: Sex Offender's Dad Says 6 Months Is Too Harsh For '20 Minutes Of Action'

Darpan News Desk IANS, 07 Jun, 2016 12:30 PM
    The father of a Stanford University student convicted of sexual assault has sparked outrage on social media by saying his son should not have been jailed for "20 minutes of action".
     
    Brock Turner, 20, was sentenced to six months in jail for sexually assaulting an unconscious woman last year.
     
    The victim's impact statement, which was read out in court, was also widely shared on social media.
     
    The judge expressed concern about the impact of prison on Turner.
     
    Prosecutors said that in January 2015, Turner had been seen by two witnesses sexually assaulting the woman, who was lying on the ground, unconscious, on the Stanford campus.
     
    They said Turner had tried to run away when challenged by the witnesses, but the pair had tackled him and held him until police officers arrived.
     
    A former top swimmer at the university, Turner was found guilty in March of three felony charges. Prosecutors wanted a sentence of six years in state prison for him, the Mercury News reported.
     
    His sentencing, to six months and probation, also required him to register as a sex offender for the rest of his life.
    In an excerpt of a statement to the court before the sentencing, Brock's father, Dan, said his son's life had been "deeply altered forever".
     
    "His life will never be the one that he dreamed about and worked so hard to achieve," he said.
    "That is a steep price to pay for 20 minutes of action out of his 20 plus years of life."
     
    Many Twitter users reacted angrily, both to the sentence and the tone of the father's letter.
     
    Some 28,000 people have also signed a petition to recall the sentencing judge, Aaron Persky, for passing what they called a "lenient sentence".

    MORE International ARTICLES

    Reluctantly, Obama Embracing His Role As The Anti-Trump

    WASHINGTON — He won't be on November's ballot, but President Barack Obama is slowly embracing his role as the anti-Trump, taking on the Republican front-runner in ways that no other Democrat can.

    Reluctantly, Obama Embracing His Role As The Anti-Trump

    Rare Blue Diamond Sets New Record At Sotheby's Auction

    Rare Blue Diamond Sets New Record At Sotheby's Auction
    A rare blue diamond bucked the recent downturn in the auction market when it was sold for $30.8 million at Sotheby's, setting a new record.

    Rare Blue Diamond Sets New Record At Sotheby's Auction

    9-Year-Old Reporter Defends Homicide Coverage After Backlash

    9-Year-Old Reporter Defends Homicide Coverage After Backlash
    A 9-year-old reporter who wrote about a suspected murder in her small Pennsylvania town is defending herself after some locals lashed out about a young girl covering violent crimes.

    9-Year-Old Reporter Defends Homicide Coverage After Backlash

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes
    WHISTLER, B.C. — The Whistler Blackcomb mountain resort is planning a renaissance over the next few years that would include real estate developments in the later phases and a price tag of about $345 million.

    Whistler Blackcomb's $345-million Plan Includes Indoor Water Play Area, Townhomes

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden
    The former U.S. intelligence contractor said Tuesday that the so-called Panama Papers, which were given to journalists by an anonymous source, demonstrate that "change doesn't happen by itself."

    Panama Papers Leaks Show Change Doesn't Happen By Itself, Says Edward Snowden

    Allergan, Pfizer Call Off Proposed $160b Merger

    Allergan, Pfizer Call Off Proposed $160b Merger
    The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland — on paper — to reduce its tax bill.

    Allergan, Pfizer Call Off Proposed $160b Merger